Chinese PE Multimodality Imaging Artificial Intelligence Study

ConditionsPulmonary Embolism Chronic Thromboembolic Pulmonary Hypertension Chronic Thromboembolic Pulmonary Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age14+

SponsorChina-Japan Friendship Hospital

About this trial

The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.

Eligibility criteria

Qualifiers

14 Years and older

Patients suspected of PE

Disqualifiers

Pregnant women

Refuse to follow up

Incomplete or discontinued imaging scans

Insufficient quality of image data to allow for analysis

Trial design

Treatments tested in this trial

Artificial Intelligence

Treatment groups

1,500 Participants

are divided into 4 treatment groups

Sponsors and collaborators

China-Japan Friendship Hospital

Lead sponsor

Source ClinicalTrials.gov